# Pro-med Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pro-med-technology

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.pmdt.com.cn
- Latest round: Series A (May 3, 2017)
- Investors on record: 1

## About

Established in 2013 and based in Beijing, China, Pro-med Technology is a reagent developer that provides colloidal gold quantitative reagent, fluorescent quantitative reagent, molecular diagnostic reagent and relevant devices or reagents. In September 2021, the company raised venture funding from Zero2IPO Ventures. At present, the company has 8,000 square meters of production and development site, 1,000 square meters of GMP workshop, more than 30 core patents authorized, more than 80 product registration certificates, the products have been sold to more than 5,000 medical institutions in more than 30 provinces. 

The company's product line includes more than 60 detection reagents of health elements, pediatric infection, cardiovascular and cerebrovascular diseases, stomach health, and women's health. The company's clotting product line is represented by the CWPS thromboelastogram, which can provide a variety of detection reagents such as ordinary cup, heparinase cup, platelet aggregation, rapid coagulation and quality control products for different clinical situations. The company has also developed a series of molecular microfluidic detection reagents represented by the nine joint examination of respiratory pathogens and the twelve joint examination of respiratory pathogens.

In the future, the company will focus on the development of coagulation product line, increase the company's R & D capital investment, and set up a coagulation R & D center in Suzhou.

## Funding rounds

- Series A, May 3, 2017 — Maintrend Capital

## Investors

- Maintrend Capital (https://capitalatlas.ai/funds/maintrend-capital) — Series A